(Q77609350)
Statements
Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial (English)
C Müller
S Pongratz
J Pidlich
E Penner
A Kaider
M Schemper
M Raderer
W Scheithauer
1 October 1998